Gilad Oren bought APRE
March 12, 2026 · Form 4 insider transaction
Gilad Oren bought 80,700 shares of Aprea Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
80,700
Price
$0.00
Total value
N/A
InsiderGilad Oren
Role—
SecurityStock Options (Right to Buy)
Transaction codeA: Grant or award
Transaction dateMarch 12, 2026
Filing dateMarch 16, 2026
Shares owned after80,700
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Twenty-five percent of these options vest on March 12, 2027, with the remaining options vesting ratably over the following 36 months, subject to the reporting person's continued employment through and including the applicable vesting dates and subject to acceleration under certain conditions.